Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.38
- Piotroski Score 6.00
- Grade Overweight
- Symbol (SYK)
- Company Stryker Corporation
- Price $390.14
- Changes Percentage (1.16%)
- Change $4.46
- Day Low $384.60
- Day High $390.37
- Year High $398.20
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
- Last Earnings 08/07/2024
- Ex-Dividend for 5/16 Dividend 09/30/2024
- Dividend Payable 10/31/2024
- Today N/A
- Next Earnings (Estimated) 02/04/2025
- Fiscal Year End N/A
- Average Stock Price Target $291.50
- High Stock Price Target $420.00
- Low Stock Price Target $245.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $8.78
- Trailing P/E Ratio 39.79
- Forward P/E Ratio 39.79
- P/E Growth 39.79
- Net Income $3.17 B
Income Statement
Quarterly
Annual
Latest News of SYK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Ohio Democratic Rep. Emilia Sykes wins reelection as Rep. Kaptur's race remains too early to call
Rep. Emilia Sykes won reelection in Ohio's northeast district, while Rep. Marcy Kaptur's race remains undecided. Sykes defeated Republican Kevin Coughlin, but faces a residency challenge. Kaptur leads...
By AP NEWS | 2 weeks ago -
Stryker Corp (SYK) Q3 2024 Earnings Call Highlights: Strong Organic Sales Growth and Strategic ...
CEO Kevin Lobo is optimistic about the company's growth trajectory, aiming for 10% organic growth in Q4. CFO Glenn Boehnlein highlights cost-saving initiatives driving margin expansion. Strong interna...
By Yahoo! Finance | 3 weeks ago -
Tyson Fury reveals wife, Paris, had miscarriage on eve of fight with Oleksandr Usyk
Tyson Fury revealed the heartbreaking loss of his wife's miscarriage before his fight against Usyk. Despite the personal tragedy, Fury lost the fight but plans to return to the ring later this year....
By Fox News | 4 weeks ago
